We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 3.51% | 14.75 | 14.00 | 15.50 | 14.75 | 14.00 | 14.25 | 239,794 | 10:40:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 644k | -2.04M | -0.0208 | -7.09 | 13.96M |
8 August 2024
OptiBiotix Health plc
("OptiBiotix" or the "Company" or the "Group")
Result of AGM
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care announces that at the AGM held earlier today, all resolutions were duly passed.
The full voting results will be available on the website in due course here: https://www.optibiotix-ir.com/content/investors/
For further information, please contact:
OptiBiotix Health plc |
||
Neil Davidson, Chairman |
Contact via Walbrook below |
|
Stephen O'Hara, Chief Executive |
|
|
|
|
|
Cairn Financial Advisers LLP (NOMAD) |
Tel: 020 7213 0880 |
|
Liam Murray / Jo Turner / Ludovico Lazzaretti
|
|
|
Peterhouse Capital Limited (Broker) |
Tel: 020 7220 9797 |
|
Duncan Vasey / Lucy Williams |
|
|
|
|
|
Walbrook PR Ltd |
Mob: 07876 741 001 |
|
Anna Dunphy |
|
|
About OptiBiotix - www.optibiotix.com
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.
1 Year Optibiotix Health Chart |
1 Month Optibiotix Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions